Exelon Corporation Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Exelon Corporation Common Stock trades at $41.67 (market cap $42.99B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.08 (market cap $6.04B). The key difference: Exelon Corporation Common Stock is far larger — about 7.1× Iovance Biotherapeutics Inc. Common Stock's market cap, and Exelon Corporation Common Stock pays a 4.03% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| EXC | IOVA | |
|---|---|---|
Market Cap | $42.99B | $6.04B |
Volume | 7,570,408 | 14,805,993 |
Sector | Utilities | Health |
52-Week High | $50.29 | $14.82 |
52-Week Low | $40.20 | $1.81 |
Enterprise Value | $93.85B | $5.97B |
Dividend Yield | 4.03% | — |
Typical Hold Time | — | 0 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →